Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb trial of rhPDGF-BB gel for partial-thickness burn wounds
CTR20233683Phase 2Completed
- Sponsor
- Huaren Biotech
- Start
- Nov 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in thermal injury and cutaneous burn comparing rhPDGF-BB gel with Placebo gel (2 arms). Primary endpoint: Time to complete healing of target wound. Started Nov 2023; status: completed.
02
Drugs
becaplermin
03
Conditions
thermal injurycutaneous burn
Beyond the preview
Go deeper on CTR20233683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233683.